Recent research trials surrounding Retatrutide , specifically the high-dose formulation referred to as ZPHC, reveal a impressive effect on weight loss and related health conditions . Researchers anticipate that this dual acting , affecting both GLP-1 and GIP systems, has the potential to provide a major improvement in the treatment of overweight an